Unknown

Dataset Information

0

ACE2 expression in adipose tissue is associated with COVID-19 cardio-metabolic risk factors and cell type composition.


ABSTRACT: COVID-19 severity has varied widely, with demographic and cardio-metabolic factors increasing risk of severe reactions to SARS-CoV-2 infection, but the underlying mechanisms for this remain uncertain. We investigated phenotypic and genetic factors associated with subcutaneous adipose tissue expression of Angiotensin I Converting Enzyme 2 ( ACE2 ), which has been shown to act as a receptor for SARS-CoV-2 cellular entry. In a meta-analysis of three independent studies including up to 1,471 participants, lower adipose tissue ACE2 expression was associated with adverse cardio-metabolic health indices including type 2 diabetes (T2D) and obesity status, higher serum fasting insulin and BMI, and lower serum HDL levels (P<5.32x10 -4 ). ACE2 expression levels were also associated with estimated proportions of cell types in adipose tissue; lower ACE2 expression was associated with a lower proportion of microvascular endothelial cells (P=4.25x10 -4 ) and higher macrophage proportion (P=2.74x10 -5 ), suggesting a link to inflammation. Despite an estimated heritability of 32%, we did not identify any proximal or distal genetic variants (eQTLs) associated with adipose tissue ACE2 expression. Our results demonstrate that at-risk individuals have lower background ACE2 levels in this highly relevant tissue. Further studies will be required to establish how this may contribute to increased COVID-19 severity.

SUBMITTER: El-Sayed Moustafa JS 

PROVIDER: S-EPMC7430606 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications


COVID-19 severity has varied widely, with demographic and cardio-metabolic factors increasing risk of severe reactions to SARS-CoV-2 infection, but the underlying mechanisms for this remain uncertain. We investigated phenotypic and genetic factors associated with subcutaneous adipose tissue expression of Angiotensin I Converting Enzyme 2 ( <i>ACE2</i> ), which has been shown to act as a receptor for SARS-CoV-2 cellular entry. In a meta-analysis of three independent studies including up to 1,471  ...[more]

Similar Datasets

| S-EPMC9119844 | biostudies-literature
| S-SCDT-EMM-2022-15904 | biostudies-other
| S-EPMC2940764 | biostudies-literature
| S-EPMC5339333 | biostudies-literature
2022-02-01 | E-MTAB-10129 | biostudies-arrayexpress
| S-EPMC8381800 | biostudies-literature
| S-SCDT-EMM-2020-13038 | biostudies-other
| S-EPMC7829196 | biostudies-literature
| S-EPMC3130500 | biostudies-literature
| S-EPMC8193025 | biostudies-literature